LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 41 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,290,000 | +3.2% | 500,000 | 0.0% | 0.43% | +11.7% |
| Q2 2021 | $2,220,000 | -39.0% | 500,000 | 0.0% | 0.38% | -42.0% |
| Q1 2021 | $3,640,000 | -4.6% | 500,000 | 0.0% | 0.66% | -9.9% |
| Q4 2020 | $3,815,000 | -16.0% | 500,000 | 0.0% | 0.74% | -26.2% |
| Q3 2020 | $4,540,000 | +7.3% | 500,000 | 0.0% | 1.00% | -2.9% |
| Q2 2020 | $4,230,000 | +71.3% | 500,000 | 0.0% | 1.03% | +57.4% |
| Q1 2020 | $2,470,000 | -31.4% | 500,000 | 0.0% | 0.65% | +95.2% |
| Q4 2019 | $3,600,000 | -33.4% | 500,000 | 0.0% | 0.33% | -44.6% |
| Q3 2019 | $5,405,000 | -16.8% | 500,000 | 0.0% | 0.60% | -5.8% |
| Q2 2019 | $6,500,000 | +31.6% | 500,000 | 0.0% | 0.64% | +43.5% |
| Q1 2019 | $4,940,000 | -5.0% | 500,000 | 0.0% | 0.45% | -45.5% |
| Q4 2018 | $5,200,000 | – | 500,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,290,000 | 0.43% |
| Orbimed Advisors | 8,466,783 | $38,778,000 | 0.43% |
| Sio Capital Management, LLC | 182,630 | $836,000 | 0.27% |
| Eversept Partners, LP | 349,919 | $1,602,629 | 0.11% |
| SAMLYN CAPITAL, LLC | 1,474,108 | $6,752,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 320,273 | $1,467,000 | 0.04% |
| PURA VIDA INVESTMENTS, LLC | 245,492 | $1,124,000 | 0.03% |
| SANDERS MORRIS HARRIS LLC | 35,000 | $160,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 176,500 | $808,000 | 0.02% |
| Ergoteles LLC | 65,827 | $301,000 | 0.01% |